Ophthalmic depot formulations for periocular or subconjunctival administration

Details for Australian Patent Application No. 2002342694 (hide)

Owner Novartis AG

Inventors Bodmer, David; Schoch, Christian; Ahlheim, Markus; Ausborn, Michael

Agent Davies Collison Cave

Pub. Number AU-B-2002342694

PCT Number PCT/EP02/10314

PCT Pub. Number WO2003/024420

Priority 0122318.9 14.09.01 GB

Filing date 13 September 2002

Wipo publication date 1 April 2003

Acceptance publication date 24 August 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/50 (2006.01) - Pyridazines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 0122318.9 14.09.01 GB

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002342694

24 August 2006 Application Accepted

  Published as AU-B-2002342694

21 December 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002342695-DEVICE FOR PRODUCTION OF A PHARMACEUTICAL FILM

2002342693-DIMERIC AND MULTIMERIC ANTI- GEN BINDING STRUCTURE